Coffee Consumption, Serum Copeptin, and Selected Echocardiographic Parameters in Patients with ADPKD: A Cross-Sectional Study
- 1Department of Internal Medicine and Nephrology, Bağcılar Training and Research Hospital, University of Health Sciences, 34200 Istanbul, Türkiye
- 2Department of Internal Medicine, Bağcılar Training and Research Hospital, University of Health Sciences, 34200 Istanbul, Türkiye
- 3Department of Cardiology, Bağcılar Training and Research Hospital, University of Health Sciences, 34200 Istanbul, Türkiye
Abstract
Background/Objectives: Coffee consumption has been suggested to influence arginine vasopressin-related pathways and cardiovascular function. However, its relationships with serum copeptin and cardiac parameters in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear. This study aimed to investigate the association between habitual coffee consumption and serum copeptin concentrations and selected echocardiographic parameters in patients with ADPKD. Methods: In this cross-sectional study, 73 patients with ADPKD were classified as coffee consumers (n = 35) or non-consumers (n = 38). Serum copeptin measurements were available for 62 patients. Coffee consumption was assessed using a standardized questionnaire and expressed as grams of dry coffee per month. Multivariable models were used to assess associations with log-transformed copeptin, mitral annular e′ velocity, and E/e′ ratio. Results: Serum copeptin levels were lower among coffee consumers than non-consumers (median, 263.51 vs. 332.77 ng/L; p = 0.013). After adjustment, coffee consumption was associated with lower log-transformed copeptin levels (B = −0.263; p = 0.047), although this association was not statistically significant when using heteroskedasticity-consistent (HC3) robust standard errors (p = 0.074). Coffee consumers had higher mitral annular e′ velocity (8.61 vs. 5.86 cm/s; p < 0.001), which remained significant after adjustment (B = 2.531; p < 0.001), and a lower E/e′ ratio (B = −4.548; p = 0.007). Conclusions: In this ADPKD cohort, coffee consumption was associated with lower serum copeptin levels, higher mitral annular e′ velocity, and lower E/e′ ratio. These findings raise the hypothesis that habitual coffee consumption may be associated with vasopressin–copeptin system activity and diastolic myocardial relaxation in patients with ADPKD. However, the copeptin association was not robust to HC3 analysis, and the echocardiographic findings should be considered exploratory.
Related
- Effects of Pulmonary Vein Isolation on Left Atrial Hemodynamic and Mechanical Function: Insights from Advanced and Emerging Echocardiographic Parameters in Responders and Non-Responders
- Fish Consumption and Sustainability: A Modeling Study Evaluating the Effects of Fish and Canned Fish Consumption on Nutritional Adequacy and Selected Metrics of Environmental Impact
- Echocardiographic Parameters in the Assessment of Tricuspid Regurgitation Prognosis: What Is New?
- Association Between Local Ascending Aortic Elastic Properties and Left Ventricular Global Longitudinal Strain in Patients with Multiple Sclerosis: A Cross-Sectional Case–Control Echocardiographic Study
- Association of Exercise-Induced Pulmonary Hypertension and Echocardiographic Parameters of Cardiac Function: A Systematic Review and Meta-Analysis
BibTeX
@article{esen2026coffee,
title = {{Coffee Consumption, Serum Copeptin, and Selected Echocardiographic Parameters in Patients with ADPKD: A Cross-Sectional Study}},
author = {Bennur Esen and Ahmet Engin Atay and Ferdi Karagoz and Irfan Sahin},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15207943},
url = {https://www.mdpi.com/2077-0383/15/20/7943},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Coffee Consumption, Serum Copeptin, and Selected Echocardiographic Parameters in Patients with ADPKD: A Cross-Sectional Study
AU - Bennur Esen
AU - Ahmet Engin Atay
AU - Ferdi Karagoz
AU - Irfan Sahin
PY - 2026
DA - 2026/10/01
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15207943
UR - https://www.mdpi.com/2077-0383/15/20/7943
AB - Background/Objectives: Coffee consumption has been suggested to influence arginine vasopressin-related pathways and cardiovascular function. However, its relationships with serum copeptin and cardiac parameters in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear. This study aimed to investigate the association between habitual coffee consumption and serum copeptin concentrations and selected echocardiographic parameters in patients with ADPKD. Methods: In this cross-sectional study, 73 patients with ADPKD were classified as coffee consumers (n = 35) or non-consumers (n = 38). Serum copeptin measurements were available for 62 patients. Coffee consumption was assessed using a standardized questionnaire and expressed as grams of dry coffee per month. Multivariable models were used to assess associations with log-transformed copeptin, mitral annular e′ velocity, and E/e′ ratio. Results: Serum copeptin levels were lower among coffee consumers than non-consumers (median, 263.51 vs. 332.77 ng/L; p = 0.013). After adjustment, coffee consumption was associated with lower log-transformed copeptin levels (B = −0.263; p = 0.047), although this association was not statistically significant when using heteroskedasticity-consistent (HC3) robust standard errors (p = 0.074). Coffee consumers had higher mitral annular e′ velocity (8.61 vs. 5.86 cm/s; p < 0.001), which remained significant after adjustment (B = 2.531; p < 0.001), and a lower E/e′ ratio (B = −4.548; p = 0.007). Conclusions: In this ADPKD cohort, coffee consumption was associated with lower serum copeptin levels, higher mitral annular e′ velocity, and lower E/e′ ratio. These findings raise the hypothesis that habitual coffee consumption may be associated with vasopressin–copeptin system activity and diastolic myocardial relaxation in patients with ADPKD. However, the copeptin association was not robust to HC3 analysis, and the echocardiographic findings should be considered exploratory.
SN - 2077-0383
ER -